首页> 外文期刊>Chromatographia >Investigation of enantiomeric separation of chiral drugs by CE using Cu(II)-clindamycin complex as a novel chiral selector
【24h】

Investigation of enantiomeric separation of chiral drugs by CE using Cu(II)-clindamycin complex as a novel chiral selector

机译:铜(II)-克林霉素配合物为新型手性选择剂的CE手性药物对映体分离研究

获取原文
获取原文并翻译 | 示例
           

摘要

The enantiomeric separation of several basic drugs was investigated using copper(II)-clindamycin as a new chiral selector. The results show that the chiral selector allows high-resolution separation of some racemic basic drugs, including tropicamide, propranolol, sotalol, bisoprolol, epinephrine, esmolol, atenolol, and metoprolol. The enantioselectivity was influenced by parameters such as the type of metal ion, ratio of clindamycin and Cu(II), pH of the background electrolyte, clindamycin concentration, applied voltage, and capillary temperature. The optimal separation conditions were determined to be 20 mM clindamycin/10 mM Cu~(2+), pH 9.06, at 20 kV and 22 °C within 25 min.
机译:使用铜(II)-克林霉素作为新的手性选择剂,研究了几种基本药物的对映体分离。结果表明,手性选择剂可以对某些外消旋的基础药物进行高分辨率分离,其中包括托吡卡胺,普萘洛尔,索他洛尔,比索洛尔,肾上腺素,艾司洛尔,阿替洛尔和美托洛尔。对映选择性受诸如金属离子类型,克林霉素和Cu(II)的比例,背景电解质的pH,克林霉素浓度,施加电压和毛细管温度等参数影响。在20 kV和22°C下25分钟内,确定最佳分离条件为20 mM克林霉素/ 10 mM Cu〜(2 +),pH 9.06。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号